- Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients
-
Ozyilkan O, Yalcintas , Baskan S
- KMID: 760329
- Korean J Intern Med.
- 1999 Jul;14(2):15-19.
The treatment of infectious complications in cancer patients has evolved as a consequence of the developments in the chemotherapy of cancer patients. In this prospective, randomized study, we... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia
-
Choi JY, Kim CO, Park YS, Yoon HJ, Shin SY, Kim YK, Kim MS, Kim YA, Song YG, Yong D, Lee K, Kim JM
- KMID: 1715874
- Yonsei Med J.
- 2006 Feb;47(1):63-69.
- doi: 10.3349/ymj.2006.47.1.63
Multiple antibiotic reisistance threatens successful treatment of Acinetobacter baumannii infections worldwide. Increasing interest in the well-known activity of sulbactam against the genus Acinetobacter has been aroused. The purpose of this... -
- CITED
-
- Close
- SHARE
-
- Close
- Identification of ACT-1 Plasmid-Mediated AmpC beta-Lactamase Producing Citrobacter freundii from a Chinese Patient
-
Wei Y, Wang J
- KMID: 1781305
- Ann Lab Med.
- 2013 Jan;33(1):86-88.
- doi: 10.3343/alm.2013.33.1.86
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
